The Biden administration on Thursday released a framework that “would allow authorities to take over the patent of some drugs that were developed with the help of taxpayer dollars and then license the invention to another entity,” Bloomberg reports. The NAM pushes back: Though the administration billed the move as a way to ensure that medications are “reasonably available and affordable…
Originally published on National Association of Manufacturers: Original article